Skip to main content
Caplight Logo









Remmie Health

Remmie Health

Private
Seattle, WashingtonHealthcare & Life Scienceshttps://remmiehealth.com/

Last Round

Accelerator

Jun 30, 2025

Total Funding Raised

$4.85M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Remmie Health is a digital health company that provides an AI-powered smart otoscope and telehealth platform for at-home ear, nose, and throat (ENT) diagnosis and monitoring.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Telemedicine, D2C Brands, Health IoT

Business Model

B2B2C

Customer Profile

Hardware Sales, Subscription SaaS

AI Layer

Application

Keywords

digital otoscopetelehealthremote diagnosticsconnected carepediatric healthremote monitoringENT monitoringvirtual carehealth IoTmedical deviceat-home diagnosticsDTC healthclinical workflowAI-guided imagingtelemedicine

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Remmie Health Comparables

Compare Remmie Health with similar companies based on industry and business-model similarity.

Remmie Health comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Blueberry Pediatrics
79%
TympaHealth
76%
TytoCare
76%

Remmie Health Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorJun 30, 2025
GrantDec 4, 2024
GrantAug 13, 2024
GrantJun 12, 2024
GrantOct 10, 2023
Grant
Oct 31, 2022

Key People

Founding team and executive leadership

Tong Sun

Co-Founder, COO Product Management Consultant

Founding Team

Kosin Chen

Chief Product Officer, Sr. Product Manager

Executive Team

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 26, 2026

    Monthly visitors grew 71% MoM, reaching 3.6K.

  • Aug 13, 2025

    Selected as a top finalist for the Pediatric track at Pitch. Launch.

Remmie Health Filings

Explore SEC and related filing metadata, where available.

Remmie Health filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Remmie Health's valuation, stock price, and market status.

Is Remmie Health a public or private company?

Remmie Health is a private company.

What is the current stock price of Remmie Health?

Remmie Health is a private company with no public stock price. No recent secondary market data is available.

How much is Remmie Health worth (valuation)?

Valuation information for Remmie Health is not publicly available.

Can I buy Remmie Health stock?

Remmie Health shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Remmie Health's last funding round?

Remmie Health's most recent funding round was Grant on December 4, 2024.

Who are the main investors in Remmie Health?

Key investors in Remmie Health include Techstars, National Institute on Deafness and Other Communication Disorders.

Will Remmie Health IPO soon?

No public IPO plans have been announced for Remmie Health.

How can I track Remmie Health secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Remmie Health's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSeattle, Washington
Employee Range15
Year Founded2018
Last FundingJun 30, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?